Brigatinib Manufacturer List: Takeda, Lonza & 72+ API Suppliers
Brigatinib manufacturer guide: Takeda (brand), Lonza (CDMO), and 72+ API vendors. Patent expiries: China 2026, US 2035. How to choose a reliable supplier for generic development.
Butanedioic acid 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide;Prucalopride Succinate API;Prucalopride Succinate WS
CAS:179474-85-2
Chemical Formula:C22H32ClN3O7
Molecular Weight:485.96
Availability: R&D; Commercialization
⬤ CAS No.179474-85-2
⬤ Packaging type:20kg barrel;5kg barrel;1kg bag;500g bag ; Customized Packaging
| Product Name | Prucalopride Succinate |
| CAS No. | 179474-85-2 |
| Chemical Formula | C22H32ClN3O7 |
| Molecular Weight | 485.96 |
| EINECS | 680-639-5 |
| Related Categories | Prucalopride; pharmaceutical intermediates; small molecule inhibitors |
| Melting point | >196°C (dec.) |
| Storage Conditions | Sealed in dry,Room Temperature |
| Solubility | Soluble in DMSO (a little), methanol (a little) |
| Form | Solid |
| Color | White to light brown |
| InChIKey | QZRSNVSQLGRAID-UHFFFAOYSA-N |
| Biological Activity | Prucalopride is a selective, high-affinity 5-HT4 receptor agonist that acts on the impaired gastrointestinal motility associated with chronic constipation, thereby normalizing bowel movements. |
| Application | The main application of **Prucalopride Succinate** is as an active pharmaceutical ingredient (API) in the production of medications used to treat **chronic idiopathic constipation (CIC)**. It functions as a selective serotonin (5-HT4) receptor agonist, which stimulates colonic motility and facilitates bowel movements. |
Exceptional Product Quality
“We have been sourcing pharmaceuticals from Tianming Pharmaceutical for several years now, and their product quality has consistently exceeded our expectations. Each batch undergoes rigorous testing, ensuring we receive only the highest quality products. This reliability has significantly contributed to our trust and satisfaction with their services. Highly recommended!”
June 15, 2023
Outstanding Technical Guidance
“The technical guidance provided by Tianming Pharmaceutical’s team has been invaluable to our research and development projects. Their experts are knowledgeable, responsive, and always willing to assist with detailed explanations and support. Their guidance has enabled us to optimize our processes and achieve remarkable results. We couldn’t ask for a better partner.”
June 15, 2023
Superior Service Experience
“Our experience with Tianming Pharmaceutical has been nothing short of excellent. Their customer service team is exceptionally responsive and dedicated to meeting our needs. From initial consultation to after-sales support, they have provided seamless, professional service. Their commitment to customer satisfaction is truly commendable.”
June 15, 2023
Precise Product Specifications
“Tianming Pharmaceutical has impressed us with their adherence to precise product specifications. Each order is meticulously packaged and delivered exactly as requested, ensuring that we receive products that perfectly meet our requirements. Their attention to detail and commitment to accuracy have made them a trusted supplier for our business.”
June 15, 2023
Brigatinib manufacturer guide: Takeda (brand), Lonza (CDMO), and 72+ API vendors. Patent expiries: China 2026, US 2035. How to choose a reliable supplier for generic development.
This article summarizes 2025 latest research on ibrutinib’s long-term side effects, covering atrial fibrillation, bleeding, hypertension, infections and joint issues. It compares safety with newer BTK inhibitors and notes real-world treatment discontinuation risks.
Orforglipron vs retatrutide: oral small‑molecule GLP‑1 agonist vs triple‑hormone injectable. Phase 3 weight loss data, dosing schedules, side effects, regulatory status, and API manufacturing differences.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.